ANIX compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

ANIXAnixa Biosciences Inc

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

ANIXAnixa Biosciences Inc

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

ANIX: latest quarter not drawable.Method ›

Price

rebased to 0%

ANIX, solidLLY, dashed

ANIXAnixa Biosciences Inc

3.08· pre 3.08· delayed

Mkt cap$106.2MRevenue—Revenue—

LLYELI Lilly & Co

1,407.25· pre 1,425.17· delayed

Pre-marketNov 4 '26delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Pre-marketNov 4 '26delayed

ANIXAnixa Biosciences Inc

LLYELI Lilly & Co

3.08pre 3.08delayed

Price

1,407.25pre 1,425.17delayed

$106.2M

Mkt cap

$1.3T

—

Revenue

$24.4BQ3 FY26

—

Revenue

$65.2BFY25

ANIX3.08vsLLY1,407.25Pre-marketNov 4 '26delayed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ANIX 0

None

Shared 0

No disclosed counterparties: ANIX.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Role chip = supplier or customerSource: SEC EDGAR